Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation. Men ... Show More
Jan 2026
Creative Discussion: A New Antitrust Podcast From ITIF
Join Joseph Coniglio, Director of Antitrust and Innovation at The Schumpeter Project, ITIF, as he inaugurates Creative Discussion: An Antitrust Podcast. In this first episode, Coniglio engages in an in-depth discussion with Herb Hovenkamp, James G. Dinan Professor at the Universi ... Show More
38m 27s
Jul 2025
The Case for Smarter AI Regulation, With Matt Perault
Regulating how AI is used—not how it's built—is the only way to protect innovation and give small startups a fair shot. Rob and Jackie sit down with Matt Perault, Head of Artificial Intelligence Policy at Andreessen Horowitz, to discuss the significant burden regulatory framework ... Show More
25m 11s
May 2025
Decoding the Techno-Economic Power Struggle, With Alex Capri
There is a clear linkage between technology and national security, economic strength and social stability. Rob and Jackie sit down with Alex Capri, author of Techno-Nationalism: How It's Reshaping Trade, Geopolitics and Society to discuss how nations leverage technological innova ... Show More
21m 17s
Feb 2023
Calling Check: Technology Competition with China
This week, Mike and Jude are joined by Emily Kilcrease, director of the Energy, Economics, and Security program at CNAS, who formerly served as deputy assistant U.S. trade representative and National Security Council director for international trade, investment, and development. ... Show More
33m 10s
Jun 2024
Leading with science: A deep dive on biotech
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ... Show More
17m 43s
Nov 2022
The Covid Vaccine Is Fueling A Race For All Kinds Of Cures
Messenger RNA technology made it possible for scientists and drugmakers to quickly develop a Covid-19 vaccine. Now, pharmaceutical companies are racing to use mRNA for other illnesses, including flu, cancer and rare genetic diseases. Dr. Drew Weissman, one of the researchers who ... Show More
26m 58s